Annual CFI
-$205.60 M
-$180.41 M-716.36%
December 31, 2024
Summary
- As of March 4, 2025, MLTX annual cash flow from investing activities is -$205.60 million, with the most recent change of -$180.41 million (-716.36%) on December 31, 2024.
- MLTX annual CFI is now -716.36% below its all-time high of -$25.18 million, reached on December 31, 2023.
Performance
MLTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$147.33 M
-$205.61 M-352.79%
December 31, 2024
Summary
- As of March 4, 2025, MLTX quarterly cash flow from investing activities is -$147.33 million, with the most recent change of -$205.61 million (-352.79%) on December 31, 2024.
- Over the past year, MLTX quarterly CFI has dropped by -$205.61 million (-352.79%).
- MLTX quarterly CFI is now -226.07% below its all-time high of $116.87 million, reached on December 31, 2023.
Performance
MLTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$205.60 M
-$264.20 M-450.83%
December 31, 2024
Summary
- As of March 4, 2025, MLTX TTM cash flow from investing activities is -$205.60 million, with the most recent change of -$264.20 million (-450.83%) on December 31, 2024.
- Over the past year, MLTX TTM CFI has dropped by -$264.20 million (-450.83%).
- MLTX TTM CFI is now -450.83% below its all-time high of $58.60 million, reached on September 30, 2024.
Performance
MLTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MLTX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -716.4% | -352.8% | -450.8% |
| 3 y3 years | - | -849.8% | -1521.9% |
| 5 y5 years | - | -849.8% | -1521.9% |
MLTX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -716.4% | at low | -226.1% | +15.5% | -450.8% | at low |
| 5 y | 5-year | -716.4% | at low | -226.1% | +15.5% | -450.8% | at low |
| alltime | all time | -716.4% | at low | -226.1% | +15.5% | -450.8% | at low |
MoonLake Immunotherapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$205.60 M(+716.4%) | -$147.33 M(-352.8%) | -$205.60 M(-450.8%) |
| Sep 2024 | - | $58.28 M(-166.4%) | $58.60 M(-133.7%) |
| Jun 2024 | - | -$87.74 M(+204.6%) | -$174.06 M(+136.4%) |
| Mar 2024 | - | -$28.80 M(-124.6%) | -$73.64 M(+192.4%) |
| Dec 2023 | -$25.18 M | $116.87 M(-167.0%) | -$25.18 M(-80.9%) |
| Sep 2023 | - | -$174.38 M(-1475.6%) | -$132.15 M(<-9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $12.68 M(-35.5%) | $0.00(-100.0%) |
| Mar 2023 | - | $19.65 M(+98.4%) | -$12.68 M(-60.8%) |
| Dec 2022 | -$32.34 M | $9.90 M(-123.4%) | -$32.34 M(-23.4%) |
| Sep 2022 | - | -$42.23 M(<-9900.0%) | -$42.24 M(>+9900.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$16.00 K(0.0%) |
| Mar 2022 | - | -$16.00 K | -$16.00 K |
FAQ
- What is MoonLake Immunotherapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual CFI year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly CFI year-on-year change?
- What is MoonLake Immunotherapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM CFI year-on-year change?
What is MoonLake Immunotherapeutics annual cash flow from investing activities?
The current annual CFI of MLTX is -$205.60 M
What is the all time high annual CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash flow from investing activities is -$25.18 M
What is MoonLake Immunotherapeutics annual CFI year-on-year change?
Over the past year, MLTX annual cash flow from investing activities has changed by -$180.41 M (-716.36%)
What is MoonLake Immunotherapeutics quarterly cash flow from investing activities?
The current quarterly CFI of MLTX is -$147.33 M
What is the all time high quarterly CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash flow from investing activities is $116.87 M
What is MoonLake Immunotherapeutics quarterly CFI year-on-year change?
Over the past year, MLTX quarterly cash flow from investing activities has changed by -$205.61 M (-352.79%)
What is MoonLake Immunotherapeutics TTM cash flow from investing activities?
The current TTM CFI of MLTX is -$205.60 M
What is the all time high TTM CFI for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM cash flow from investing activities is $58.60 M
What is MoonLake Immunotherapeutics TTM CFI year-on-year change?
Over the past year, MLTX TTM cash flow from investing activities has changed by -$264.20 M (-450.83%)